Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis clinical trial (NCT00678210). Contact the study team or your healthcare provider for specific answers.

Question 2

How does CP-690,550 compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis clinical trial (NCT00678210). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with this medication?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis clinical trial (NCT00678210). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis clinical trial (NCT00678210). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis clinical trial (NCT00678210). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my current medications affect my eligibility for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis clinical trial (NCT00678210). Contact the study team or your healthcare provider for specific answers.

What this study is about